Apellis Pharmaceuticals I... (APLS)

APLS trades at $28.44, 42.2% above the near-term max pain of $20 expiring Aug 15, 2025 (0 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is stable across expirations ($16-$30), indicating stable market expectations. Key magnetic zone at 20 where 3 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for APLS shows stable levels around 21.83, reflecting balanced market expectations. The 64% spread signals divergent expectations across timeframes. Most levels below 28.44 may cap rallies. Strong magnetic level at 20 (3 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.